Elliott Simon P
Regional Laboratory for Toxicology, City Hospital, Birmingham B18 7QH, UK.
Ther Drug Monit. 2004 Aug;26(4):432-40. doi: 10.1097/00007691-200408000-00014.
There has been much publicity regarding the use and abuse of gamma-hydroxybutyrate (GHB, "liquid ecstasy," or "GBH"). GHB has been found to be an endogenous compound but has also been used for various therapeutic applications in addition to illicit use, particularly as a dietary supplement, sexual adjunct, and "party drug." Toxicological analysis was performed using urine and/or plasma specimens from 27 nonfatal instances of suspected GHB intoxication in the United Kingdom between May 1998 and May 2003. GHB was detected in the plasma and urine, invariably with the additional presence of ethanol and other drugs of abuse (eg, amphetamines, cocaine, and morphine). GBL was also detected in the majority of urine specimens analyzed but was not detected in the plasma samples (<10 mg/L). The mean plasma and urine concentrations measured as "total GBL" were found to be 245 mg/L (range 86-551 mg/L) and 1732 mg/L (range 5-5581 mg/L), respectively. This is believed to be the largest compilation of nonfatal cases from the United Kingdom.
关于γ-羟基丁酸盐(GHB,“液体摇头丸”或“GBH”)的使用及滥用已有诸多报道。GHB被发现是一种内源性化合物,但除了非法用途外,还被用于各种治疗用途,特别是作为膳食补充剂、性辅助用品和“派对药物”。对1998年5月至2003年5月期间英国27例疑似GHB中毒非致命病例的尿液和/或血浆样本进行了毒理学分析。在血浆和尿液中检测到了GHB,同时总是还存在乙醇和其他滥用药物(如苯丙胺、可卡因和吗啡)。在大多数分析的尿液样本中也检测到了GBL,但在血浆样本中未检测到(<10毫克/升)。以“总GBL”衡量的血浆和尿液平均浓度分别为245毫克/升(范围86 - 551毫克/升)和1732毫克/升(范围5 - 5581毫克/升)。据信这是来自英国的最大一批非致命病例汇编。